120 related articles for article (PubMed ID: 9219328)
1. Vasomodulatory action of clopidogrel and ticlopidine.
Yang LH; Fareed J
Thromb Res; 1997 Jun; 86(6):479-91. PubMed ID: 9219328
[TBL] [Abstract][Full Text] [Related]
2. Modulation of vasoconstriction by clopidogrel and ticlopidine.
Yang LH; Hoppensteadt D; Fareed J
Thromb Res; 1998 Oct; 92(2):83-9. PubMed ID: 9792116
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-independent vasorelaxation by ticlopidine and clopidogrel in rat caudal artery.
Froldi G; Bertin R; Dorigo P; Montopoli M; Caparrotta L
J Pharm Pharmacol; 2011 Aug; 63(8):1056-62. PubMed ID: 21718289
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits.
Herbert JM; Tissinier A; Defreyn G; Maffrand JP
Arterioscler Thromb; 1993 Aug; 13(8):1171-9. PubMed ID: 8343491
[TBL] [Abstract][Full Text] [Related]
5. Relaxant effect of 2-methyl-thio-adenosine diphosphate on rat thoracic aorta: effect of clopidogrel.
Dol-Gleizes F; Marés AM; Savi P; Herbert JM
Eur J Pharmacol; 1999 Feb; 367(2-3):247-53. PubMed ID: 10078999
[TBL] [Abstract][Full Text] [Related]
6. Defibrotide mediated inhibition of serotonin, endothelin-I, thromboxane, and serum induced contraction of canine femoral and pulmonary arterial rings.
Yang LH; Hoppensteadt DA; Iqbal O; Fareed J
Thromb Res; 1996 Nov; 84(3):167-77. PubMed ID: 8914216
[TBL] [Abstract][Full Text] [Related]
7. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
Savi P; Laplace MC; Maffrand JP; Herbert JM
J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
[TBL] [Abstract][Full Text] [Related]
8. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
Defreyn G; Gachet C; Savi P; Driot F; Cazenave JP; Maffrand JP
Thromb Haemost; 1991 Feb; 65(2):186-90. PubMed ID: 2053105
[TBL] [Abstract][Full Text] [Related]
9. Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats.
De La Cruz P; Arrebola M; González-Correa A; Martinez-Cerdán E; Moreno A; de la Cuesta FS
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):204-10. PubMed ID: 12595963
[TBL] [Abstract][Full Text] [Related]
10. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
11. Effects of clopidogrel on platelet activation and coagulation of non-anticoagulated rat blood under high shear stress.
Taka T; Okano E; Seki J; Yamamoto J
Haemostasis; 1999; 29(4):189-96. PubMed ID: 10702699
[TBL] [Abstract][Full Text] [Related]
12. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
14. Direct vasoactive properties of thienopyridine-derived nitrosothiols.
Bundhoo SS; Anderson RA; Sagan E; Dada J; Harris R; Halcox JP; Lang D; James PE
J Cardiovasc Pharmacol; 2011 Nov; 58(5):550-8. PubMed ID: 21822146
[TBL] [Abstract][Full Text] [Related]
15. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients.
David JL; Limet R
Thromb Haemost; 1999 Nov; 82(5):1417-21. PubMed ID: 10595630
[TBL] [Abstract][Full Text] [Related]
17. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments.
Kam PC; Nethery CM
Anaesthesia; 2003 Jan; 58(1):28-35. PubMed ID: 12492666
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet and antithrombotic efficacy of SR 121787, a nonpeptide orally active GP IIb/IIIa antagonist, in rabbits: comparison with clopidogrel and aspirin.
Hoffmann P; Bernat A; Savi P; Herbert JM
J Cardiovasc Pharmacol; 1997 Sep; 30(3):360-6. PubMed ID: 9300321
[TBL] [Abstract][Full Text] [Related]
19. [Modified platelet aggregation test in patients on ASA and/or clopidogrel].
Eder C; Funke U; Schulze M; Lutze G; Zimmermann M; Prasse T; Töpfer G
Hamostaseologie; 2007 Aug; 27(3):163-76. PubMed ID: 17694223
[TBL] [Abstract][Full Text] [Related]
20. [Current pharmacological principles to inhibit platelet function and their clinical implications. Focus on clopidogrel].
Schrör K
Med Klin (Munich); 2004 Aug; 99 Suppl 1():3-7. PubMed ID: 15487851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
